Apex Biotechnology Corp

TW:1733 Taiwan Biotechnology
Market Cap
$89.12 Million
NT$2.95 Billion TWD
Market Cap Rank
#19992 Global
#1014 in Taiwan
Share Price
NT$29.50
Change (1 day)
+1.37%
52-Week Range
NT$26.50 - NT$37.50
All Time High
NT$42.96
Categories
Companies in Taiwan Biotechnology
About

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health s… Read more

Apex Biotechnology Corp - Asset Resilience Ratio

Latest as of September 2025: 3.32%

Apex Biotechnology Corp (1733) has an Asset Resilience Ratio of 3.32% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
NT$76.63 Million
Cash + Short-term Investments
Total Assets
NT$2.31 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Apex Biotechnology Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Apex Biotechnology Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$76.63 Million 3.32%
Total Liquid Assets NT$76.63 Million 3.32%

Asset Resilience Insights

  • Limited Liquidity: Apex Biotechnology Corp maintains only 3.32% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Apex Biotechnology Corp Industry Peers by Asset Resilience Ratio

Compare Apex Biotechnology Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980 		Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004 		Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 		Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504 		Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 		Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990 		Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007 		Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 		Biotechnology 4.35%

Annual Asset Resilience Ratio for Apex Biotechnology Corp (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Apex Biotechnology Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.73% NT$66.10 Million NT$2.42 Billion +0.04pp
2023-12-31 2.69% NT$61.87 Million NT$2.30 Billion +0.08pp
2022-12-31 2.62% NT$65.83 Million NT$2.51 Billion -0.22pp
2021-12-31 2.84% NT$75.92 Million NT$2.67 Billion +1.48pp
2020-12-31 1.36% NT$36.01 Million NT$2.65 Billion -3.95pp
2019-12-31 5.31% NT$149.31 Million NT$2.81 Billion +2.01pp
2018-12-31 3.29% NT$83.78 Million NT$2.55 Billion +0.52pp
2017-12-31 2.77% NT$74.84 Million NT$2.70 Billion +1.48pp
2016-12-31 1.29% NT$32.37 Million NT$2.50 Billion -2.31pp
2015-12-31 3.60% NT$97.01 Million NT$2.69 Billion -2.58pp
2014-12-31 6.18% NT$163.51 Million NT$2.64 Billion -0.83pp
2013-12-31 7.02% NT$191.13 Million NT$2.72 Billion +5.26pp
2012-12-31 1.76% NT$48.38 Million NT$2.75 Billion -0.23pp
2011-12-31 1.99% NT$42.60 Million NT$2.14 Billion -0.01pp
2010-12-31 2.00% NT$38.99 Million NT$1.95 Billion -19.03pp
2009-12-31 21.03% NT$373.15 Million NT$1.77 Billion +19.69pp
2008-12-31 1.34% NT$19.88 Million NT$1.49 Billion -20.18pp
2007-12-31 21.51% NT$334.31 Million NT$1.55 Billion +17.55pp
2005-12-31 3.97% NT$44.45 Million NT$1.12 Billion -5.61pp
2004-12-31 9.57% NT$95.22 Million NT$994.56 Million -33.20pp
2003-12-31 42.78% NT$412.54 Million NT$964.43 Million +21.04pp
2002-12-31 21.74% NT$174.34 Million NT$801.97 Million --
pp = percentage points